Task: Answer the multiple choice question.
Question: Which drug exhibits a 1.533% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any additional words.
Options:
a) Cc1ccc(S(=O)(=O)c2cc3c(=O)n4ccccc4nc3n(CCc3ccccc3)c2=N)cc1
b) CN1CCN(CC#CC(C)(O)C2CC3C=CC2C3)CC1.Cl
c) C/C(=N\N1CCCCC1c1cccnc1)c1c(O)n(C2CCCCC2)c(=S)[nH]c1=O
d) CCc1ccc(N(CC(=O)N2CCN(Cc3ccccc3)CC2)S(C)(=O)=O)cc1
e) O=C(CSc1nnc(CNC(=O)c2c(F)cccc2F)o1)NCc1ccccc1Cl
Answer: b. CN1CCN(CC#CC(C)(O)C2CC3C=CC2C3)CC1.Cl
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CN1CCN(CC#CC(C)(O)C2CC3C=CC2C3)CC1.Cl
CN1CCN(CC#CC(C)(O)C2CC3C=CC2C3)CC1.Cl
2-(2-bicyclo[2.2.1]hept-5-enyl)-5-(4-methylpiperazin-1-yl)pent-3-yn-2-ol;hydrochloride